Immunogenicity 1128

summary
Sample ID
3942
Response
Negative
Tumor Type
Rectal cancer
Gene Symbol
GPD2
Transcript ID
ENST00000409674
HLA INFO
C*16:01
TCR INFO

No TCR info found!

T cell Tumor cell C*16:01
sequence
Full length protein sequence (727 aa)
MAFQK
1
AVKGT
6
ILVGG
11
GALAT
16
VLGLS
21
QFAHY
26
RRKQM
31
NLAYV
36
KAADC
41
ISEPV
46
NREPP
51
SREAQ
56
LLTLQ
61
NTSEF
66
DILVI
71
GGGAT
76
GSGCA
81
LDAVT
86
RGLKT
91
ALVER
96
DDFSS
101
GTSSR
106
STKLI
111
HGGVR
116
YLQKA
121
IMKLD
126
IEQYR
131
MVKEA
136
LHERA
141
NLLEI
146
APHLS
151
APLPI
156
MLPVY
161
KWWQL
166
PYYWV
171
GIKLY
176
DLVAG
181
SNCLK
186
SSYVL
191
SKSRA
196
LEHFP
201
MLQKD
206
KLVGA
211
IVYYD
216
GQHND
221
ARMNL
226
AIALT
231
AARYG
236
AATAN
241
YMEVV
246
SLLKK
251
TDPQT
256
GKVRV
261
SGARC
266
KDVLT
271
GQEFD
276
VRAKC
281
VINAT
286
GPFTD
291
SVRKM
296
DDKDA
301
AAICQ
306
PSAGV
311
HIVMP
316
GYYSP
321
ESMGL
326
LDPAT
331
SDGRV
336
IFFLP
341
WQKMT
346
IAGTT
351
DTPTD
356
VTHHP
361
IPSEE
366
DINFI
371
LNEVR
376
NYLSC
381
DVEVR
386
RGDVL
391
AAWSG
396
IRPLV
401
TDPKS
406
ADTQS
411
ISRNH
416
VVDIS
421
ESGLI
426
TIAGG
431
KWTTY
436
RSMAE
441
DTINA
446
AVKTH
451
NLKAG
456
PSRTV
461
GLFLQ
466
GGKDW
471
SPTLY
476
IRLVQ
481
DYGLE
486
SEVAQ
491
HLAAT
496
YGDKA
501
FEVAK
506
MASVT
511
GKRWP
516
IVGVR
521
LVSEF
526
PYIEA
531
EVKYG
536
IKEYA
541
CTAVD
546
MISRR
551
TRLAF
556
LNVQA
561
AEEAL
566
PRIVE
571
LMGRE
576
LNWDD
581
YKKQE
586
QLETA
591
RKFLY
596
YEMGY
601
KSRSE
606
QLTDR
611
SEISL
616
LPSDI
621
DRYKK
626
RFHKF
631
DADQK
636
GFITI
641
VDVQR
646
VLESI
651
NVQMD
656
ENTLH
661
EILNE
666
VDLNK
671
NGQVE
676
LNEFL
681
QLMSA
686
IQKGR
691
VSGSR
696
LAILM
701
KTAEE
706
NLDRR
711
VPIPV
716
DRSCG
721
GL
726
Mutation Information
DNA mutation:
None
Peptide Range:
414 ~ 438
Mut AA position:
426 (13 in Wild Type peptide)
Alignment
Wild Type:
"QSISRNHVVDISESGLITIAGGKWT
||||||||||||.||||||||||||
Mutant:
QSISRNHVVDISKSGLITIAGGKWT"
reference

Science, 2015

Immunogenicity of somatic mutations in human gastrointestinal cancers

Gene Name (from Reference) GPD2

clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

autologous DCs

Assay

IFNg ELISPOT assay